131 related articles for article (PubMed ID: 2044053)
1. Endometrial adenocarcinoma in Norway. A study of a total population.
Abeler VM; Kjørstad KE
Cancer; 1991 Jun; 67(12):3093-103. PubMed ID: 2044053
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of adenomyosis in endometrial carcinoma.
Hall JB; Young RH; Nelson JH
Gynecol Oncol; 1984 Jan; 17(1):32-40. PubMed ID: 6693051
[TBL] [Abstract][Full Text] [Related]
3. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
Carcangiu ML; Chambers JT
Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
[TBL] [Abstract][Full Text] [Related]
4. [Clinical studies of 145 cases of endometrial carcinoma--analysis of prognostic factors, especially pathological types].
Fukuma K; Tohya T; Souda Y; Fuzisaki S; Maeyama M; Mimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1508-14. PubMed ID: 3772201
[TBL] [Abstract][Full Text] [Related]
5. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus.
Ambros RA; Kurman RJ
Cancer; 1992 Mar; 69(6):1424-31. PubMed ID: 1371712
[TBL] [Abstract][Full Text] [Related]
6. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population.
Abeler VM; Kjørstad KE; Berle E
Int J Gynecol Cancer; 1992 Jan; 2(1):9-22. PubMed ID: 11576230
[TBL] [Abstract][Full Text] [Related]
8. [Treatment and prognosis of pT2 endometrial carcinoma].
Tamura H; Nakai Y; Nagano T; Ohara A; Shibamoto T; Nakayama T; Ohnishi T; Wakutani K; Taniguchi F; Suzuki N
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):315-20. PubMed ID: 2045699
[TBL] [Abstract][Full Text] [Related]
9. [A clinicopathologic evaluation of "depth" in cases of endometrial adenocarcinoma].
Sakamoto A; Hirai Y; Yamauchi K; Masubuchi K; Hasumi K
Gan No Rinsho; 1990 May; 36(6):711-4. PubMed ID: 2348558
[TBL] [Abstract][Full Text] [Related]
10. Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases.
Abeler VM; Kjørstad KE
Gynecol Oncol; 1991 Mar; 40(3):207-17. PubMed ID: 2013441
[TBL] [Abstract][Full Text] [Related]
11. Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases.
Abeler VM; Kjørstad KE; Nesland JM
Cancer; 1991 Jul; 68(1):98-105. PubMed ID: 2049761
[TBL] [Abstract][Full Text] [Related]
12. Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion.
Ambros RA; Kurman RJ
Gynecol Oncol; 1992 Jun; 45(3):235-9. PubMed ID: 1612497
[TBL] [Abstract][Full Text] [Related]
13. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma.
Connelly PJ; Alberhasky RC; Christopherson WM
Obstet Gynecol; 1982 May; 59(5):569-75. PubMed ID: 7070727
[TBL] [Abstract][Full Text] [Related]
15. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
16. The prognostic importance of steroid receptors in endometrial carcinoma.
Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer.
Hanson MB; van Nagell JR; Powell DE; Donaldson ES; Gallion H; Merhige M; Pavlik EJ
Cancer; 1985 Apr; 55(8):1753-7. PubMed ID: 3978563
[TBL] [Abstract][Full Text] [Related]
18. [MRI in evaluation of myometrial invasion and staging of endometrial carcinoma].
Kaketa M; Takemoto O; Akamine M; Iwasaki H; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):859-66. PubMed ID: 2794618
[TBL] [Abstract][Full Text] [Related]
19. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
20. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
